Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 41.00
Ask: 42.00
Change: 0.30 (0.72%)
Spread: 1.00 (2.439%)
Open: 42.00
High: 42.00
Low: 42.00
Prev. Close: 41.70
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Q3 Results

1 Aug 2022 07:00

RNS Number : 3496U
Benchmark Holdings PLC
01 August 2022
 

1 August 2022

 

Benchmark Holdings plc

 

("Benchmark" or the "Company")

 

Notice of Q3 Results

 

Webcast for analysts and institutional investors

Equity Development webcast for retail investors

 

Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business, will announce its Q3 results for the three month period ended 30 June 2022, on Thursday 25th August 2022. 

 

Webcast for analysts and institutional investors at 9am UK time

 

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a webcast for analysts and institutional investors on that day at 09:00am UK time. To register your interest, please contact benchmark@mhpc.com.

 

Equity Development webcast for retail investors at 12:00pm UK time

 

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a separate webcast for retail investors and wealth managers at 12.00pm UK time. The webcast is open to all existing and potential shareholders. Questions can be submitted during the presentation which will be addressed at the end.

 

To register please visit: https://www.equitydevelopment.co.uk/news-and-events/benchmark-q3results-presentation-aug25

 

 

Enquiries

For further information, please contact:

Benchmark Holdings plc

Tel: 020 3696 0630

Trond Williksen, CEO

Septima Maguire, CFO

Ivonne Cantu, Investor Relations

Numis (Broker and NOMAD)

Tel: 020 7260 1000

James Black, Freddie Barnfield, Duncan Monteith

MHP Communications

Tel: 020 3128 8990

Katie Hunt, Reg Hoare, Charlie Protheroe

benchmark@mhpc.com

 

Equity Development

Hannah Crowe

 

020 7065 2690

 

About Benchmark

Benchmark is a market leading aquaculture biotechnology company. Benchmark's mission is to drive sustainability in aquaculture by delivering products and solutions in genetics, advanced nutrition and health which improve yield, growth and animal health and welfare.

Through a global footprint in 26 countries and a broad portfolio of products and solutions, Benchmark addresses the major aquaculture species - salmon, shrimp, sea bass and bream, and tilapia, in all the aquaculture regions around the world. Find out more at www.benchmarkplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORWPUPAMUPPGBG
Date   Source Headline
8th Oct 20152:43 pmRNSFurther re. potential acquisition
8th Oct 201512:15 pmRNSPotential acquisition and suspension of shares
8th Oct 201512:15 pmRNSSuspension - Benchmark Holdings Plc
30th Sep 20157:00 amRNSSalmoBreed breakthrough
30th Sep 20157:00 amRNSTotal Voting Rights
16th Sep 20157:00 amRNSBlock Admission Application
27th Jul 20157:00 amRNSAcquisition
13th Jul 20153:40 pmRNSHolding(s) in Company
23rd Jun 20157:00 amRNSHalf Yearly Report
6th May 20155:46 pmRNSHolding(s) in Company
30th Apr 201512:44 pmRNSHolding(s) in Company
29th Apr 20157:00 amRNSTrading Statement
23rd Apr 201512:34 pmRNSHolding(s) in Company
17th Mar 201512:25 pmRNSHolding(s) in Company
10th Mar 20151:13 pmRNSDirector Share Options
5th Mar 201510:43 amRNSResult of AGM
26th Feb 20152:39 pmRNSHolding(s) in Company
16th Feb 20151:51 pmRNSHolding(s) in Company
3rd Feb 201512:59 pmRNSHolding(s) in Company
2nd Feb 20157:00 amRNSAcquisition
27th Jan 20157:01 amRNSFinal Results
8th Jan 20152:21 pmRNSHolding(s) in Company
6th Jan 201510:53 amRNSHolding(s) in Company
19th Dec 20144:32 pmRNSHolding(s) in Company
19th Dec 20144:26 pmRNSHolding(s) in Company
19th Dec 20144:24 pmRNSHolding(s) in Company
19th Dec 20144:20 pmRNSHolding(s) in Company
19th Dec 20144:14 pmRNSHolding(s) in Company
18th Dec 20144:38 pmRNSResult of General Meeting
10th Dec 201412:44 pmRNSProposed Placing and Acquisitions Update
27th Nov 20144:50 pmRNSNotice of Posting of Circular for General Meeting
24th Nov 20147:00 amRNSPlacing & Proposed Acquisitions Replacement
21st Nov 20145:56 pmRNSPlacing, Proposed Acquisitions and Trading Update
1st Sep 20147:00 amRNSHypoPet Agreement
16th Jul 20145:58 pmRNSHolding(s) in Company
4th Jul 20148:03 amRNSHolding(s) in Company
24th Jun 20147:00 amRNSHalf Yearly Report
23rd Jun 20148:45 amRNSHolding(s) in Company
16th May 20147:00 amRNSTrading Update and Notice of Results
12th Mar 20144:05 pmRNSDirector's shareholding
11th Mar 201410:41 amRNSResult of AGM
17th Feb 20147:00 amRNSAcquisition
14th Feb 201410:00 amRNSPosting of Annual Report and Notice of AGM
24th Jan 20146:22 pmRNSAmendment: Issue of Equity
23rd Jan 20144:57 pmRNSIssue of Equity
23rd Dec 20134:57 pmRNSHolding(s) in Company
19th Dec 201312:13 pmRNSHolding(s) in Company
18th Dec 20138:00 amRNSAdmission and First Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.